Skip to content
10-K

Annual Report

WEREWOLF THERAPEUTICS, INC. HOWL

0001785530-26-000006

← back to feed
Filed
Mar 27, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 20, 2026 48.6M sh
Shares Diluted FY 2025 · Dec 31, 2025 46.81M sh
Shares Diluted FY 2025 · Dec 31, 2024 43.86M sh
Capex FY 2025 · Dec 31, 2025 $0
Capex FY 2025 · Dec 31, 2024 $254K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$60.29M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$56.19M
Long Term Debt FY 2025 · Dec 31, 2025 $32.09M
Cash And Equivalents FY 2025 · Dec 31, 2025 $57.05M
Cash And Equivalents FY 2025 · Dec 31, 2024 $111M
Stockholders Equity FY 2025 · Dec 31, 2025 $24.81M
Stockholders Equity FY 2025 · Dec 31, 2024 $73.39M
Stockholders Equity FY 2025 · Dec 31, 2023 $111.37M
Current Liabilities FY 2025 · Dec 31, 2025 $36.15M
Current Liabilities FY 2025 · Dec 31, 2024 $15.18M
Total Liabilities FY 2025 · Dec 31, 2025 $44.59M
Total Liabilities FY 2025 · Dec 31, 2024 $53.54M
Current Assets FY 2025 · Dec 31, 2025 $58.59M
Current Assets FY 2025 · Dec 31, 2024 $113.07M
Total Assets FY 2025 · Dec 31, 2025 $69.4M
Total Assets FY 2025 · Dec 31, 2024 $126.93M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.33
Eps Diluted FY 2025 · Dec 31, 2024 −$1.63
Eps Basic FY 2025 · Dec 31, 2025 −$1.32
Eps Basic FY 2025 · Dec 31, 2024 −$1.63
Sga Expense FY 2025 · Dec 31, 2025 $15.85M
Sga Expense FY 2025 · Dec 31, 2024 $19.05M
Rd Expense FY 2025 · Dec 31, 2025 $44.83M
Rd Expense FY 2025 · Dec 31, 2024 $56.43M
Net Income FY 2025 · Dec 31, 2025 −$60.82M
Net Income FY 2025 · Dec 31, 2024 −$70.52M
Operating Income FY 2025 · Dec 31, 2025 −$60.68M
Operating Income FY 2025 · Dec 31, 2024 −$73.59M